By Unknown Kamis, 30 Juli 2015 CHF clinical trials Entresto evidence-based medicine manipulating clinical research Novartis sacubitril Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...